• 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2023.0530
    In order to standardize the clinical rational application of hepatoprotective drugs, the Chinese Pharmacists Association organized medical and pharmaceutical experts in relevant fields in China to conduct literature search and review on the clinical classification of liver injury, prescription recommendations for different drugs and medication for special groups, forming a consensus on prescription review of hepatoprotective drugs, providing theoretical reference for the clinical application of hepatoprotective drugs.
  • 2023.0526
    Guideline Objective(s): by the end of this project of CPG adaptation, the following outcomes will be achieved; 1. Establish multidisciplinary clinical practice guidelines that standardize the clinical practices in preventing and managing cancer therapy-induced oral mucositis and rationalizing the utilization of the relevant information 2. Reduced OM incident rate among the defined patient population by 30 % - 40%
Registration process and operational mode of a CPG registry